Uslu Yurteri, E. Et Al. 2023. Secukinumab experience in patients with axial spondyloarthritis: A 3-year real life data of a single centre. Ulusal Romatoloji Dergisi , vol.15, no.3 , 113-119.

Uslu Yurteri, E., Şahin Eroğlu, D., Aydemir Gülöksüz, E. G., İlbay, A., Turgay, T. M., Kınıklı, G., ... Ateş, A.(2023). Secukinumab experience in patients with axial spondyloarthritis: A 3-year real life data of a single centre. Ulusal Romatoloji Dergisi , vol.15, no.3, 113-119.

Uslu Yurteri, EMİNE Et Al. "Secukinumab experience in patients with axial spondyloarthritis: A 3-year real life data of a single centre," Ulusal Romatoloji Dergisi , vol.15, no.3, 113-119, 2023

Uslu Yurteri, EMİNE Et Al. "Secukinumab experience in patients with axial spondyloarthritis: A 3-year real life data of a single centre." Ulusal Romatoloji Dergisi , vol.15, no.3, pp.113-119, 2023

Uslu Yurteri, E. Et Al. (2023) . "Secukinumab experience in patients with axial spondyloarthritis: A 3-year real life data of a single centre." Ulusal Romatoloji Dergisi , vol.15, no.3, pp.113-119.

@article{article, author={EMİNE USLU Et Al. }, title={Secukinumab experience in patients with axial spondyloarthritis: A 3-year real life data of a single centre}, journal={Ulusal Romatoloji Dergisi}, year=2023, pages={113-119} }